SEC Tracker
Get the app

Dare Bioscience DARE

Dare faces Nasdaq delisting risk

Form
8-K
Filed
Importance
Major
  1. Received Nasdaq notice on Sep 28, 2026
  2. Stock price below $1.00 for 30 days
  3. 180-day compliance period until Mar 29, 2027
  4. Potential delisting if not compliant

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Dare Bioscience files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Lunai Bioworks LNAI public float $21M, Dec 31, 2025
  2. Imunon IMNN public float $21M, Jun 30, 2025
  3. Armata Pharmaceuticals ARMP public float $21M, Jun 30, 2025
  4. Fibrogen FGEN public float $21M, Jun 30, 2025
  5. Aptose Biosciences APTOF public float $22M, Jun 28, 2025